New Drug for Chronic Heart Failure

• Autores: Diane S. Aschenbrenner
• Localización: American Journal of Nursing, ISSN 0002-936X, Vol. 115, Nº. 8, 2015, págs. 48-49
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • * Ivabradine (Corlanor) is a new drug used in the treatment of stabilized chronic heart failure. It decreases the risks of worsening heart failure and hospitalization.

    * Ivabradine is contraindicated if there is an acute exacerbation of heart failure, hypotension, or various cardiac pathologies that alter the generation of a heartbeat or the conductivity of the electrical charge within the heart.

    * The most common adverse effects are bradycardia, hypertension, atrial fibrillation, and temporary vision disturbances characterized by flashes of light (known as phosphenes).